Elias Dakwar, MD
New York State Psychiatric Institute · NYSPI/Columbia · NYSPI
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Elias Dakwar, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:49 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05690503 · Glutamatergic Modulation as a Treatment for Depressive Symptoms Among Patients With Post-acute Sequelae of COVID (PASC): A Pilot TrialNew York State Psychiatric Institute · active not recruiting · Post-acute Sequelae of COVID-19, Depressive Symptoms, Cognitive Dysfunction · principal investigator
- Ph2NCT04084860 · The Role of Brief Potent Glutamatergic Modulation in Addressing Problem DrinkingNew York State Psychiatric Institute · recruiting · Alcohol Use Disorder · principal investigator
- Ph3NCT03345173 · Facilitating Rapid Naltrexone InitiationNew York State Psychiatric Institute · active not recruiting · Opioid Dependence · principal investigator
- Ph3NCT03344419 · Glutamatergic Modulation to Facilitate the Behavioral Treatment of Cocaine Use DisordersNew York State Psychiatric Institute · suspended · Cocaine Use Disorder · principal investigator
- Ph1NCT02946489 · Facilitating the Behavioral Treatment of Cannabis Use DisorderNew York State Psychiatric Institute · completed · Cannabis Dependence · principal investigator
- Ph2NCT02596022 · The Effect of Glutamatergic Modulation on Cocaine Self-administrationNew York State Psychiatric Institute · completed · Cocaine Dependence · principal investigator
- Ph2/Ph3NCT02539511 · Glutamatergic Modulation of Disordered Alcohol UseNew York State Psychiatric Institute · completed · Alcohol Dependence · principal investigator
- Ph2NCT02437344 · Glutamatergic Modulation to Facilitate Naltrexone Initiation in Opioid DependenceNew York State Psychiatric Institute · completed · Opioid Dependence · principal investigator
- Ph2NCT01790490 · Glutamatergic Modulation of Cocaine-related DeficitsNew York State Psychiatric Institute · completed · Cocaine Dependence · principal investigator
- Ph1/Ph2NCT01535937 · The Effect of Brief Potent Glutamatergic Modulation on Cocaine DependenceNew York State Psychiatric Institute · terminated · Cocaine Dependence · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:49 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- The role of brief potent glutamatergic modulation in addressing problem drinking: a randomized, controlled trialR01AA027509 · NIAAA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI Elias Dakwar · fiscal years 2019 to 2022Named on NCT04084860
- Glutamatergic Modulation to Facilitate Naltrexone Initiation: A Randomized, Controlled TrialR01DA042070 · NIDA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI Elias Dakwar · fiscal years 2017 to 2020Named on NCT03345173
- Pharmacological Facilitation of Behavioral Modification for Cocaine Use DisordersU01DA040647 · NIDA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI Elias Dakwar · fiscal years 2017 to 2020Named on NCT03344419
- Substance Abuse Treatment Development and Clinical Research MentoringK24DA029647 · NIDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Frances Rudnick Levin · fiscal years 2010 to 2019Named on NCT02946489
- The Effect of Brief Potent Glutamatergic Modulation on Disordered Alcohol UseR21AA023010 · NIAAA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI Elias Dakwar · fiscal years 2015 to 2016Named on NCT02539511
- Brief Potent Glutamatergic Modulation: Applications for Cocaine DependenceK23DA031771 · NIDA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI Elias Dakwar · fiscal years 2011 to 2015Named on NCT01535937
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.